Skip to main content

Glatiramer Acetate

Therapy Area
Multiple Sclerosis - MS
API Technology
Peptide
Formulation
Injectable
Development Status
Available
Available Regulatory Filing
USA
Europe
New Zealand
Innovator Brand (US)
COPAXONE

We are here to help, if you have any country specific requirements - please Contact Us.